Medtronic Biotech Presence: “Pawn Or Rook?” Is VP Oesterle’s Challenge

Biologics delivery to aid organ restoration is a frontier that will permit Medtronic to advance beyond its core strengths in electromechanical implants, according to Senior VP-Medicine & Technology Stephen Oesterle

More from Archive

More from Medtech Insight